Infantile Hemangioma
Conditions
Interventions
Hemangioma depth 6mm:external application of timolol eye drops
Sponsors
Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
All
Age
No minimum to 0.5 Years
Inclusion criteria
Inclusion criteria: 1. 0-6 months of age. 2. It was clinically diagnosed as single mixed type infantile hemangioma, with obvious hyperplasia before treatment, and no treatment was given. 3. The area of infantile hemangioma should not exceed 1% of the body surface area of infantile hemangioma. 4. Skin type III/IV.
Exclusion criteria
Exclusion criteria: 1. Patients who have received other treatments in other hospitals or our hospital. 2. Combined with ulcer lesions. 3. Timolol eye drops cannot be used in special places, such as around the eyes, lips, airway, etc.. 4. Patients with clinically significant or unstable systemic disease or congenital disease, including a history of asthma or a family history of asthma, congenital heart disease or a family member with a history of congenital heart disease, or organic diseases of kidney or liver, were excluded on the basis of possible interference with the safety indicators of the study results.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depth; | — |
Secondary
| Measure | Time frame |
|---|---|
| Colore;area; | — |
Countries
China
Contacts
Public ContactXiaoxi Lin
Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
Outcome results
None listed